Abstract 3920
Background
About 80%-85% of patients with pancreatic cancer are unresectable at first diagnosis. Several studies have examined nab-paclitaxel plus gemcitabine (NG) in patients with locally advanced pancreatic cancer (LAPC) and metastatic pancreatic cancer (MPC). The objective of this analysis was to evaluate the effectiveness of NG as first-line treatment in this specific patient population.
Methods
We searched Pubmed for eligible studies from the day of inception to April 15th, 2018 for studies of chemo(radiation)therapy-naïve patients who accepted NG as first-line treatment of unresectable pancreatic cancer (UPC). Overall objective response rate (ORR), 1-year overall survival (OS) and 6-month progression free survival (PFS) rates were estimated by randomized-effect model. Subgroup analyses were conducted in LAPC and MPC.
Results
Of 890 patients included from 16 studies, 53 patients were LAPC and 837 patients were MPC. Median OS from the start of NG of all patients ranged from 8.7 months to 20.0 months with a 1-year survival rate of 50.9% (95%CI 40.1% to 61.8%). Median PFS ranged from 2.2 months to 8.4 months with a 6-month PFS rate of 52.8% (95%CI 33.2% to 72.3%). In single arm analysis, the overall ORR in unresectable pancreatic cancer was 34.4% (95%CI 25.3% to 43.5%). In patients with LAPC, 90.6% (48/53) underwent surgery and the R0 resection rate was 81.2% (ranging from 70% to 100%), achieving a 1-year survival rate of 97.5%. In patients with MPC, the ORR was 30.8% and the 1-year survival rate was 44.6%. Five hundred and fifty six grade 3/4 adverse events and no death caused by toxicity were reported in 15 studies consisting of 871 patients.
Conclusions
This is the first meta-analysis to evaluate the effectiveness of NG for UPC. More than 50% of patients with UPC treated with NG survived longer than 12 months. NG showed favorable tumor reducing effect with acceptable toxicity profile. Randomized controlled trials are needed to confirm the efficacy of NG in patients with LAPC.
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
National Science Fund for Distinguished Young Scholars (81625016).
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract